Skip to main content
. 2020 Apr 19;6(3):283–289. doi: 10.1002/vms3.266

Figure 2.

Figure 2

Combination of methadone and doxorubicin does not result in enhanced cancer cell growth inhibition in canine transitional cell carcinoma (TCC), canine osteosarcoma Abrams (OSA) and canine hemangiosarcoma DAL‐4 (HSA). Cells pretreated with doxorubicin first (a) and methadone first (b) were incubated for 72 hr and cell viability was measured. Mean ± SD of three experiments performed independently is shown